Our Take on All Things Technology

The Hassle of Anticoagulation Management and The Positive Impact of mHealth-Part 1

Posted by Danielle Pouletsos

July 21, 2016 at 7:58 AM

This is a guest blog by Danielle Pouletsos. She completed her BS in Health Science with a concentration in Public Health and Community Health Education in 2005. She earned her Master of Public Health degree at the University of Illinois at Chicago and specialized in Public Health Informatics in 2009. She has worked in the non-profit sector for over 10 years serving those with HIV/AIDS and Developmental Disabilities. 

Read more about public health, mhealth and related topics on Danielle’s blog.

 This is part 1 of a two part series that explores the real world impact of mHealth.

Part I – The Hassle of Anticoagulation Management

Warfarin, or Coumadin, is the most widely prescribed anticoagulant and has been on the pharmaceutical market for about 60 years. Anticoagulation therapy saves many lives each year, but also poses extreme health risks from side effects, mismanagement, and birth defects. Termed a “blood-thinner,” Warfarin inhibits the production of Vitamin K in the body, which is essential for the body’s natural blood clotting cascade. There are a variety of diagnoses that will influence practitioners to decide whether or not to place a patient on anticoagulation therapy, either for short term, or chronic use. There are also multiple diagnoses in which Warfarin therapy is the patient’s only option.


Read more

Topics: mHealth, What is Trending, ResearchKit, Wearables & IoT, DigitalHealth

It’s Elementary, Says (IBM) Watson!

Posted by Shyam Deval

July 20, 2016 at 8:47 AM

You read that right - it’s not Sherlock saying it this time! IBM Watson’s cognitive computing capabilities and superhuman intelligence stands it in good stead to switch roles with the legendary fictitious detective Sherlock Holmes who could crack the most mind-boggling of mysteries, find answers to the unanswered questions everyone had and draw insights from information in a way no one could even fathom!


Read more

Topics: Mobile App Development, Enterprise Mobility, Wearables & IoT, Mobile Analytics

Apple ResearchKit's Maiden Venture With A Pharma Company !

Posted by Ranjani Rao

July 19, 2016 at 7:01 AM

More than an year after its introduction, Apple's ResearchKit platform is finally being used by a pharma company in its clinical trial. GlaxoSmithKline ( GSK) is using ResearchKit to gather valuable patient data from 300 rheumatoid arthritis patients in a study. 
Read more

Topics: mHealth, Mobile App Development, What is Trending, ResearchKit, DigitalHealth, ios

Glucose Advisors Diabetes IoT App

Posted by McKinley Hackett

July 14, 2016 at 8:00 AM

A few weeks ago Glucose Advisors has added a fantastic resource for people with diabetes to better manage their health and activity.  There are 1.25 Americans living with T1D (Type 1 Diabetes), including 200,000 youth (less than 20 years old).  Less than 1/3 of the people with T1D are achieving target glucose control levels and there is $14B spent on T1D-associated annual healthcare costs each year.

Read more

Topics: mHealth, Mobile App Development, What is Trending, Wearables & IoT, DigitalHealth, IOT

Apple ResearchKit And Its Impact So Far

Posted by Ranjani Rao

July 13, 2016 at 6:52 AM

When Apple came out with the ResearchKitmore than a year ago, its goal was to "use technology to solve some of the biggest problems facing medical research". And from then to now, there has been a lot of demonstrable progress in the field of research with the use of ResearchKit.


Read more

Topics: mHealth, What is Trending, ResearchKit, DigitalHealth, ios

Mobile app and custom software development blog subscription CTA

About Us

BTC is a committed team of passionate designers and perfectionist coders providing high quality custom web and mobile application development services since 2004.

Subscribe to Technology Articles by Email

Follow BTC